
SEC registered adviser
EcoR1 Capital
EcoR1 Capital is a San Francisco investment firm dedicated to biotech. It backs therapeutic companies and works with their founders over the long term.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is EcoR1 Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds EcoR1 Capital joined, from press and the firm’s own posts.
Every round EcoR1 Capital joined
Round sizes, EcoR1 Capital’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet EcoR1 Capital
Events where EcoR1 Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
EcoR1 Capital is based in San Francisco, United States.
3 fund vehicles are on public registers (SEC adviser filings), including ECOR1 CAPITAL FUND QUALIFIED, L.P., ECOR1 CAPITAL FUND, L.P. and ECOR1 VENTURE OPPORTUNITY FUND, LP.
Sectors: Biotech. From the firm’s own website.
Backs biotech companies developing new medicines for diseases without good treatments. It screens for strong management, solid science and sensible financing, then researches deeply. It acts as a thought partner to founders, combining scientific and strategic understanding. From the firm’s own website.
Know before EcoR1 Capital’s next round is announced.
PRO tracks EcoR1 Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.